SHANK3 Protein - SH3 and Multiple Ankyrin Repeat Domains 3

SHANK3 Protein - SH3 and Multiple Ankyrin Repeat Domains 3

Introduction

Shank3 Protein Sh3 And Multiple Ankyrin Repeat Domains 3 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

SHANK3 (SH3 and Multiple Ankyrin Repeat Domains 3) is a critical scaffolding protein located at the postsynaptic density (PSD) of excitatory synapses[@sheng2000]. It plays a fundamental role in synapse formation, dendritic spine morphology, and synaptic signaling. Mutations in SHANK3 are causative for Phelan-McDermid syndrome (22q13.3 deletion syndrome) and have been implicated in autism spectrum disorder (ASD), intellectual disability, and neurodegenerative diseases including Alzheimer's disease and Parkinson's disease[@durand2007].

SHANK3 Protein - SH3 and Multiple Ankyrin Repeat Domains 3

Introduction

Shank3 Protein Sh3 And Multiple Ankyrin Repeat Domains 3 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

SHANK3 (SH3 and Multiple Ankyrin Repeat Domains 3) is a critical scaffolding protein located at the postsynaptic density (PSD) of excitatory synapses[@sheng2000]. It plays a fundamental role in synapse formation, dendritic spine morphology, and synaptic signaling. Mutations in SHANK3 are causative for Phelan-McDermid syndrome (22q13.3 deletion syndrome) and have been implicated in autism spectrum disorder (ASD), intellectual disability, and neurodegenerative diseases including Alzheimer's disease and Parkinson's disease[@durand2007].

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#f0f0f0;">SHANK3 Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>SHANK3</td></tr>
<tr><td><strong>Gene</strong></td><td>[SHANK3](/genes/shank3)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9BYB4](https://www.uniprot.org/uniprot/Q9BYB4)</td></tr>
<tr><td><strong>PDB ID(s)</strong></td><td>5Y5Z, 6CXN</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>223.1 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Postsynaptic density, [dendritic spines](/cell-types/dendritic-spines)</td></tr>
<tr><td><strong>Protein Family</strong></td><td>SHANK family (ProSAP/SHANK)</td></tr>
<tr><td><strong>Expression</strong></td><td>Brain (cortex, [hippocampus](/brain-regions/hippocampus), striatum)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/autism" style="color:#ef9a9a">Autism</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">13 edges</a></td>
</tr>
</table>
</div>

Structure

Domain Architecture

SHANK3 contains multiple protein-protein interaction domains[@svitkina1996]:

Splice Variants

Multiple SHANK3 isoforms exist with tissue-specific expression:

• Isoform a: Full-length, brain-specific
• Isoform b: Missing ANK repeats 2-3
• Isoform c: Alternative C-terminus

Function

Synaptic Scaffolding

SHANK3 is a master organizer of the postsynaptic density[@sheng2011]:

• PSD-95 interaction: Links to [NMDA](/entities/nmda-receptor) receptor complexes via SAP90/PSD-95
• Metabotropic glutamate receptors: Associates with group I mGluRs
• Actin cytoskeleton: Connects to actin via ankyrin repeats
• Synaptic adhesion: Binds to neurexin and other presynaptic proteins

Spine Morphogenesis

SHANK3 is essential for dendritic spine formation and maintenance:

• Spine density: Knockout reduces spine number by 40-60%
• Spine morphology: Affects head width and neck length
• Synaptic plasticity: Modulates [LTP](/mechanisms/long-term-potentiation) and LTD

Signaling Pathways

• mGluR signaling: Facilitates downstream signaling cascades
• ERK/MAPK pathway: Involved in synaptic plasticity
• PI3K/Akt pathway: Regulates neuronal survival

Role in Disease

Phelan-McDermid Syndrome

SHANK3 haploinsufficiency causes 22q13.3 deletion syndrome[@phelan2001]:

• Prevalence: ~1 in 200,000 births
• Core features: Developmental delay, absent or severely delayed speech, dysmorphic features
• Neurological: Hypotonia, seizures (25-30%), ASD traits
• Additional: Gastrointestinal issues, renal anomalies

Autism Spectrum Disorder

SHANK3 mutations are among the most common genetic causes of ASD[@boccuto2013]:

• Frequency: ~0.5-1% of ASD cases
• Inheritance: De novo dominant (most cases)
• Penetrance: Near complete
• Phenotype: Severe language impairment, intellectual disability, repetitive behaviors

Alzheimer's Disease

SHANK3 involvement in AD includes[@gong2009]:

• Synaptic loss: SHANK3 reduction correlates with cognitive decline
• [Aβ](/proteins/amyloid-beta) interaction: [Aβ](/proteins/amyloid-beta) oligomers reduce SHANK3 expression
• [Tau](/proteins/tau) pathology: Hyperphosphorylated [tau](/proteins/tau) affects SHANK3 localization
• Postsynaptic dysfunction: Early marker of synaptic vulnerability

Parkinson's Disease

• Synaptic alterations: SHANK3 changes in PD prefrontal [cortex](/brain-regions/cortex)
• LRRK2 interaction: May intersect with LRRK2 signaling pathways
• DBS effects: SHANK3 expression modified by deep brain stimulation

Therapeutic Approaches

Gene Therapy

• AAV vectors: Delivering functional SHANK3 to [neurons](/entities/neurons)
• CRISPR/Cas9: Correcting pathogenic variants
• Antisense oligonucleotides: Modulating SHANK3 expression

Small Molecule Strategies

• mGluR5 modulators: Targeting downstream signaling
• BDNF mimetics: Promoting synaptic plasticity
• AMPAkines: Enhancing glutamatergic transmission

Behavioral Interventions

• Speech therapy: Maximizing communication potential
• Occupational therapy: Improving motor skills
• Early intervention: Critical for developmental outcomes

See Also

• [SHANK3 Gene](/proteins/shank3-protein)
• [Phelan-McDermid Syndrome](/diseases/phelan-mcdermid)
• [Autism Spectrum Disorder](/diseases/autism)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Synaptic Dysfunction Pathway](/mechanisms/synaptic-dysfunction-pathway)
• [Postsynaptic Density](/psd-95-)

External Links

• [UniProt Q9BYB4](https://www.uniprot.org/uniprot/Q9BYB4)
• [PDB: SHANK3 PDZ Domain](https://www.rcsb.org/structure/5Y5Z)
• [Phelan-McDermid Syndrome Foundation](https://pmsf.org/)
• [SHANK3 in autism - Nature Reviews](https://pubmed.ncbi.nlm.nih.gov/23554086/)

Background

The study of Shank3 Protein Sh3 And Multiple Ankyrin Repeat Domains 3 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References